BIOPOL logo

Biopol Chemicals Limited IPO

ListedSME
22.33×
Subscribed
Price band
₹102 – ₹108
Open – close
06 Feb 2026
to 10 Feb 2026
Listing
13 Feb 2026

What the filing actually says

Our read of the offer document and the exchange data — not the issuer's summary of itself

We can't judge this issue yet. A verdict needs at least three independent dimensions — valuation, growth, profitability, balance sheet, issue structure, governance or demand — and this issue does not yet publish enough of them for a read that would mean anything. No offer document for this issue has been published yet. A confident score from two fields would be worse than this notice.

Dates

The issuer's tentative timetable — a date passing is not confirmation the step completed

  1. Opens
    06 Feb 2026
  2. Closes
    10 Feb 2026
  3. Listing
    13 Feb 2026

Demand and your odds

How the book filled, and what that means for an application

Subscription by category
Qualified institutionalQIB21.05x
Non-institutionalNII / HNI24.49x
Big NIIabove ₹10L27.49x
Small NII₹2L – ₹10L18.48x
Retail individualRII20.80x

12,276 applications received — how many people bid, as opposed to how much money did. Exchange figures as of 10 Feb 2026.

Chance of allotment
Retail20.80× subscribed
~1 in 20.8

Retail is 20.8× subscribed. Allotment is a lottery on a single lot, so roughly 1 in 20.8 applications gets one lot. Bidding for extra lots does not improve these odds.

HNI / NII24.49× subscribed
~1 in 24.5

HNI is 24.49× subscribed. This category is allotted proportionately, so a bid receives roughly 1/24.5 of the shares applied for, subject to the minimum-lot draw.

Derived from SEBI's allotment mechanics and the subscription figures beside it. Retail allotment is a lottery on a single lot, so applying for more lots does not improve your chance of getting something.

The offering

Terms, structure and who is selling

Terms
Price band₹102 – ₹108
Listing atSME platform
Company & valuation
ISININE0XW001014

What happened to comparable issues

The last 8 issues to list with a recorded opening price, most comparable first

Median listing gain
+0.0%
Listed up
3 of 8
Best
+90.0%
SpectraA Technology
Worst
-1.0%
Injecto Polymers
304.1× sub+90.0%
Kheria Autocompsame segment
2.5× sub+3.9%
Shakti Polytarpsame segment
11.9× sub-0.2%
Vama Wovenfabsame segment
2.5× sub+0.0%
Century Businesssame segment
57.9× sub+0.0%
Injecto Polymerssame segment
1.2× sub-1.0%
Om Galaxysame segment
2.1× sub+0.2%
47.4× sub+0.0%

Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.

Common questions

How many times is the Biopol Chemicals Limited IPO subscribed?

Biopol Chemicals Limited is subscribed 22.33× overall (QIB 21.05×, NII 24.49×, retail 20.80×). Subscription keeps changing until the issue closes; the final basis of allotment is published by the registrar.

What are the chances of allotment in the Biopol Chemicals Limited IPO?

The retail portion is subscribed 20.80×, so allotment is by lottery and the odds of receiving at least one lot are roughly 1 in 21. Applying for more lots does not improve the chance of getting something — every retail applicant competes for the same single minimum lot.

Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.

Biopol Chemicals Limited IPO — GMP, subscription & review | DocStoX